FDA Inspection 1293450 — Sucampo Pharma, LLC
The FDA completed an inspection of Sucampo Pharma, LLC on Nov 7, 2025 in Sanda. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sanda (Japan)